BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15279794)

  • 1. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of FANCD2 and NBS1 in the DNA damage response.
    Nakanishi K; Taniguchi T; Ranganathan V; New HV; Moreau LA; Stotsky M; Mathew CG; Kastan MB; Weaver DT; D'Andrea AD
    Nat Cell Biol; 2002 Dec; 4(12):913-20. PubMed ID: 12447395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Dub"bing a tumor suppressor pathway.
    Niedzwiedz W; Patel KJ
    Cancer Cell; 2005 Feb; 7(2):114-5. PubMed ID: 15710323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
    Pagano G; Youssoufian H
    Bioessays; 2003 Jun; 25(6):589-95. PubMed ID: 12766948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fanconi Anemia/BRCA pathway: new faces in the crowd.
    Kennedy RD; D'Andrea AD
    Genes Dev; 2005 Dec; 19(24):2925-40. PubMed ID: 16357213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.
    Mirchandani KD; D'Andrea AD
    Exp Cell Res; 2006 Aug; 312(14):2647-53. PubMed ID: 16859679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
    Dunn J; Potter M; Rees A; Rünger TM
    Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.
    Takata M; Ishiai M; Kitao H
    Mutat Res; 2009 Jul; 668(1-2):92-102. PubMed ID: 19622405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
    Centurion SA; Kuo HR; Lambert WC
    Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.